| ■ 영문 제목 : Global Human Tetanus Immunoglobulin Market Growth 2021-2026 | |
| ■ 상품코드 : LPI-2108K201459 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 138 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 | |
| Single User (1명 열람용) | USD3,660 ⇒환산₩5,124,000 | 견적의뢰/주문/질문 |
| Multi User (20명 열람용) | USD5,490 ⇒환산₩7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산₩10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 파상풍 인간면역글로불린의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (주사, 동결 건조 주사)와 용도별 시장규모 (성인, 어린이) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 파상풍 인간면역글로불린 시장 점유율 - 지역별 파상풍 인간면역글로불린 시장규모 - 주요지역의 종류별 시장규모 (주사, 동결 건조 주사) - 주요지역의 용도별 시장규모 (성인, 어린이) - 미주의 파상풍 인간면역글로불린 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 파상풍 인간면역글로불린 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 파상풍 인간면역글로불린 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 파상풍 인간면역글로불린 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 파상풍 인간면역글로불린 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) - 조사의 결과/결론 |
According to this latest study, the 2020 growth of Human Tetanus Immunoglobulin will have significant change from previous year. By the most conservative estimates of global Human Tetanus Immunoglobulin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Human Tetanus Immunoglobulin market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Tetanus Immunoglobulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Injection
Freeze-dried Injection
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Adults
Children
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Baxalta
CSL
Octapharma
Grifols
LFB
Biotest
Kedrion
Hualan Biological Engineering
1 Scope of the Report 2 Executive Summary 3 Global Human Tetanus Immunoglobulin by Company 4 Human Tetanus Immunoglobulin by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Human Tetanus Immunoglobulin Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Human Tetanus Immunoglobulin Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Injection Table 3. Major Players of Freeze-dried Injection Table 4. Global Human Tetanus Immunoglobulin Sales by Type (2016-2021) & (K Doses) Table 5. Global Human Tetanus Immunoglobulin Sales Market Share by Type (2016-2021) Table 6. Global Human Tetanus Immunoglobulin Revenue by Type (2016-2021) & ($ million) Table 7. Global Human Tetanus Immunoglobulin Revenue Market Share by Type (2016-2021) Table 8. Global Human Tetanus Immunoglobulin Sale Price by Type (2016-2021) Table 9. Global Human Tetanus Immunoglobulin Sales by Application (2016-2021) & (K Doses) Table 10. Global Human Tetanus Immunoglobulin Sales Market Share by Application (2016-2021) Table 11. Global Human Tetanus Immunoglobulin Value by Application (2016-2021) Table 12. Global Human Tetanus Immunoglobulin Revenue Market Share by Application (2016-2021) Table 13. Global Human Tetanus Immunoglobulin Sale Price by Application (2016-2021) Table 14. Global Human Tetanus Immunoglobulin Sales by Company (2019-2021) & (K Doses) Table 15. Global Human Tetanus Immunoglobulin Sales Market Share by Company (2019-2021) Table 16. Global Human Tetanus Immunoglobulin Revenue by Company (2019-2021) ($ Millions) Table 17. Global Human Tetanus Immunoglobulin Revenue Market Share by Company (2019-2021) Table 18. Global Human Tetanus Immunoglobulin Sale Price by Company (2019-2021) Table 19. Key Manufacturers Human Tetanus Immunoglobulin Producing Area Distribution and Sales Area Table 20. Players Human Tetanus Immunoglobulin Products Offered Table 21. Human Tetanus Immunoglobulin Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Human Tetanus Immunoglobulin Sales by Region (2016-2021) (K Doses) Table 25. Global Human Tetanus Immunoglobulin Sales Market Share by Region (2016-2021) Table 26. Global Human Tetanus Immunoglobulin Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Human Tetanus Immunoglobulin Revenue Market Share by Region (2016-2021) Table 28. Americas Human Tetanus Immunoglobulin Sales by Country (2016-2021) & (K Doses) Table 29. Americas Human Tetanus Immunoglobulin Sales Market Share by Country (2016-2021) Table 30. Americas Human Tetanus Immunoglobulin Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Human Tetanus Immunoglobulin Revenue Market Share by Country (2016-2021) Table 32. Americas Human Tetanus Immunoglobulin Sales by Type (2016-2021) & (K Doses) Table 33. Americas Human Tetanus Immunoglobulin Sales Market Share by Type (2016-2021) Table 34. Americas Human Tetanus Immunoglobulin Sales by Application (2016-2021) & (K Doses) Table 35. Americas Human Tetanus Immunoglobulin Sales Market Share by Application (2016-2021) Table 36. APAC Human Tetanus Immunoglobulin Sales by Region (2016-2021) & (K Doses) Table 37. APAC Human Tetanus Immunoglobulin Sales Market Share by Region (2016-2021) Table 38. APAC Human Tetanus Immunoglobulin Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Human Tetanus Immunoglobulin Revenue Market Share by Region (2016-2021) Table 40. APAC Human Tetanus Immunoglobulin Sales by Type (2016-2021) & (K Doses) Table 41. APAC Human Tetanus Immunoglobulin Sales Market Share by Type (2016-2021) Table 42. APAC Human Tetanus Immunoglobulin Sales by Application (2016-2021) & (K Doses) Table 43. APAC Human Tetanus Immunoglobulin Sales Market Share by Application (2016-2021) Table 44. Europe Human Tetanus Immunoglobulin Sales by Country (2016-2021) & (K Doses) Table 45. Europe Human Tetanus Immunoglobulin Sales Market Share by Country (2016-2021) Table 46. Europe Human Tetanus Immunoglobulin Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Human Tetanus Immunoglobulin Revenue Market Share by Country (2016-2021) Table 48. Europe Human Tetanus Immunoglobulin Sales by Type (2016-2021) & (K Doses) Table 49. Europe Human Tetanus Immunoglobulin Sales Market Share by Type (2016-2021) Table 50. Europe Human Tetanus Immunoglobulin Sales by Application (2016-2021) & (K Doses) Table 51. Europe Human Tetanus Immunoglobulin Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Human Tetanus Immunoglobulin Sales by Country (2016-2021) & (K Doses) Table 53. Middle East & Africa Human Tetanus Immunoglobulin Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Human Tetanus Immunoglobulin Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Human Tetanus Immunoglobulin Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Human Tetanus Immunoglobulin Sales by Type (2016-2021) & (K Doses) Table 57. Middle East & Africa Human Tetanus Immunoglobulin Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Human Tetanus Immunoglobulin Sales by Application (2016-2021) & (K Doses) Table 59. Middle East & Africa Human Tetanus Immunoglobulin Sales Market Share by Application (2016-2021) Table 60. Global Human Tetanus Immunoglobulin Sales Forecast by Type (2021-2026) & (K Doses) Table 61. Global Human Tetanus Immunoglobulin Sales Market Share Forecast by Type (2021-2026) Table 62. Global Human Tetanus Immunoglobulin Revenue Forecast by Type (2021-2026) & ($ Millions) Table 63. Global Human Tetanus Immunoglobulin Revenue Market Share Forecast by Type (2021-2026) Table 64. Global Human Tetanus Immunoglobulin Sales Forecast by Application (2021-2026) & (K Doses) Table 65. Global Human Tetanus Immunoglobulin Sales Market Share Forecast by Application (2021-2026) Table 66. Global Human Tetanus Immunoglobulin Revenue Forecast by Application (2021-2026) & ($ Millions) Table 67. Global Human Tetanus Immunoglobulin Revenue Market Share Forecast by Application (2021-2026) Table 68. Baxalta Basic Information, Human Tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors Table 69. Baxalta Human Tetanus Immunoglobulin Product Offered Table 70. Baxalta Human Tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 71. Baxalta Main Business Table 72. Baxalta Latest Developments Table 73. CSL Basic Information, Human Tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors Table 74. CSL Human Tetanus Immunoglobulin Product Offered Table 75. CSL Human Tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 76. CSL Main Business Table 77. CSL Latest Developments Table 78. Octapharma Basic Information, Human Tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors Table 79. Octapharma Human Tetanus Immunoglobulin Product Offered Table 80. Octapharma Human Tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 81. Octapharma Main Business Table 82. Octapharma Latest Developments Table 83. Grifols Basic Information, Human Tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors Table 84. Grifols Human Tetanus Immunoglobulin Product Offered Table 85. Grifols Human Tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 86. Grifols Main Business Table 87. Grifols Latest Developments Table 88. LFB Basic Information, Human Tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors Table 89. LFB Human Tetanus Immunoglobulin Product Offered Table 90. LFB Human Tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 91. LFB Main Business Table 92. LFB Latest Developments Table 93. Biotest Basic Information, Human Tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors Table 94. Biotest Human Tetanus Immunoglobulin Product Offered Table 95. Biotest Human Tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 96. Biotest Main Business Table 97. Biotest Latest Developments Table 98. Kedrion Basic Information, Human Tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors Table 99. Kedrion Human Tetanus Immunoglobulin Product Offered Table 100. Kedrion Human Tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 101. Kedrion Main Business Table 102. Kedrion Latest Developments Table 103. Hualan Biological Engineering Basic Information, Human Tetanus Immunoglobulin Manufacturing Base, Sales Area and Its Competitors Table 104. Hualan Biological Engineering Human Tetanus Immunoglobulin Product Offered Table 105. Hualan Biological Engineering Human Tetanus Immunoglobulin Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 106. Hualan Biological Engineering Main Business Table 107. Hualan Biological Engineering Latest Developments List of Figures Figure 1. Picture of Human Tetanus Immunoglobulin Figure 2. Human Tetanus Immunoglobulin Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Human Tetanus Immunoglobulin Sales Growth Rate 2016-2026 (K Doses) Figure 7. Global Human Tetanus Immunoglobulin Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Human Tetanus Immunoglobulin Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Injection Figure 10. Product Picture of Freeze-dried Injection Figure 11. Global Human Tetanus Immunoglobulin Sales Market Share by Type in 2020 Figure 12. Global Human Tetanus Immunoglobulin Revenue Market Share by Type (2016-2021) Figure 13. Human Tetanus Immunoglobulin Consumed in Adults Figure 14. Global Human Tetanus Immunoglobulin Market: Adults (2016-2021) & (K Doses) Figure 15. Human Tetanus Immunoglobulin Consumed in Children Figure 16. Global Human Tetanus Immunoglobulin Market: Children (2016-2021) & (K Doses) Figure 17. Global Human Tetanus Immunoglobulin Sales Market Share by Application (2016-2021) Figure 18. Global Human Tetanus Immunoglobulin Revenue Market Share by Application in 2020 Figure 19. Global Human Tetanus Immunoglobulin Revenue Market by Company in 2020 ($ Million) Figure 20. Global Human Tetanus Immunoglobulin Revenue Market Share by Company in 2020 Figure 21. Global Human Tetanus Immunoglobulin Sales Market Share by Regions (2016-2021) Figure 22. Global Human Tetanus Immunoglobulin Revenue Market Share by Region in 2020 Figure 23. Americas Human Tetanus Immunoglobulin Sales 2016-2021 (K Doses) Figure 24. Americas Human Tetanus Immunoglobulin Revenue 2016-2021 ($ Millions) Figure 25. APAC Human Tetanus Immunoglobulin Sales 2016-2021 (K Doses) Figure 26. APAC Human Tetanus Immunoglobulin Revenue 2016-2021 ($ Millions) Figure 27. Europe Human Tetanus Immunoglobulin Sales 2016-2021 (K Doses) Figure 28. Europe Human Tetanus Immunoglobulin Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Human Tetanus Immunoglobulin Sales 2016-2021 (K Doses) Figure 30. Middle East & Africa Human Tetanus Immunoglobulin Revenue 2016-2021 ($ Millions) Figure 31. Americas Human Tetanus Immunoglobulin Sales Market Share by Country in 2020 Figure 32. Americas Human Tetanus Immunoglobulin Revenue Market Share by Country in 2020 Figure 33. Americas Human Tetanus Immunoglobulin Sales Market Share by Type in 2020 Figure 34. Americas Human Tetanus Immunoglobulin Sales Market Share by Application in 2020 Figure 35. United States Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Human Tetanus Immunoglobulin Sales Market Share by Region in 2020 Figure 40. APAC Human Tetanus Immunoglobulin Revenue Market Share by Regions in 2020 Figure 41. APAC Human Tetanus Immunoglobulin Sales Market Share by Type in 2020 Figure 42. APAC Human Tetanus Immunoglobulin Sales Market Share by Application in 2020 Figure 43. China Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 47. India Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Human Tetanus Immunoglobulin Sales Market Share by Country in 2020 Figure 50. Europe Human Tetanus Immunoglobulin Revenue Market Share by Country in 2020 Figure 51. Europe Human Tetanus Immunoglobulin Sales Market Share by Type in 2020 Figure 52. Europe Human Tetanus Immunoglobulin Sales Market Share by Application in 2020 Figure 53. Germany Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 54. France Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Human Tetanus Immunoglobulin Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Human Tetanus Immunoglobulin Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Human Tetanus Immunoglobulin Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Human Tetanus Immunoglobulin Sales Market Share by Application in 2020 Figure 62. Egypt Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Human Tetanus Immunoglobulin Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles |
| ※본 조사보고서 [세계의 파상풍 인간면역글로불린 시장예측 2021년-2026년] (코드 : LPI-2108K201459) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 파상풍 인간면역글로불린 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |